Breaking News

Vetter Launches New Clinical Syringe Packages

April 9, 2014

Aims to jump-start syringe development process

Vetter has introduced two clinical syringe packages designed to make it easier to begin syringe development earlier in the drug development process, with the goal of cutting time-to-market. The self-contained, modular packages are designed to provide a clear roadmap through the syringe development process.
 
The company’s Clinical Syringe Standard Package includes all development activities through launch, beginning with materials selection through cGMP clinical syringe filling. The Clinical Syringe Starter Package offers a range of feasibility testing without the financial commitment to a clinical fill, beginning with the same materials selection, proceeding through feasibility testing and regulatory consultation, and ending with a non-cGMP stability run.
 
“As the market moves toward prefilled syringes,” said Vetter managing director Peter Soelkner, “We wanted to enable our customers to get an earlier start on syringe development, when it suits their compound and their business goals. Our new clinical syringe packages, coupled with the development expertise of our scientists and the advanced technology of our facilities, give our customers an easier way to pursue syringe work earlier.”

blog comments powered by Disqus
  • 16th Annual $alary $urvey

    16th Annual $alary $urvey

    Tim Wright, Editor||June 3, 2015
    Welcome to Contract Pharma’s Sixteenth Annual Salary Survey! This year’s results are derived from more than 500 respondents f

  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important